MedPath
NMPA Approval

Efgartigimod Alfa Injection

国药准字SJ20230008

ARGENX BV

June 30, 2023

Drug Information

艾加莫德α注射液

卫伟迦

注射剂

400mg/20ml/瓶

生物制品

June 30, 2023

June 29, 2028

Company Information

Applicant Company

ARGENX BV

Industriepark Zwijnaarde 7, 9052 Zwijnaarde, Belgium

Manufacturing Company

Eisenbahnstraβe 2-4, 88085 Langenargen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

艾加莫德α注射液 - NMPA 批准文号 | MedPath